Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-01-08

Clinical Trial Update: Study of K201 Injection on Restoration of Sinus Rhythm in Subjects Who Are in Atrial Fibrillation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating K201 Injection for restoration of sinus rhythm in atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • K201 Injection

Snippet

Sponsor: Sequel Pharmaceuticals, Inc | Conditions: Atrial Fibrillation | Phase 2 | Status: COMPLETED